Clinical Trials on 难治性混合表型急性白血病 in Korea, Democratic People's Republic of
总计146个结果
-
Seoul National University HospitalPharos iBio Co., Ltd.招聘中
-
Takeda主动,不招人小儿费城染色体阳性急性淋巴细胞白血病 (Ph+ALL) | Ph+ 混合表型急性白血病 (MPAL) | 费城染色体样 ALL(Ph 样 ALL)美国, 法国, 大韩民国, 中国, 西班牙, 英国, 捷克语, 葡萄牙, 巴西, 阿根廷, 意大利, 澳大利亚, 墨西哥, 荷兰, 波兰
-
Samsung Medical Center未知
-
Samsung Medical Center未知
-
Samsung Medical CenterMinistry of Health, Republic of Korea招聘中
-
Konkuk University Medical CenterChonbuk National University Hospital; Samsung Medical Center; Pusan National University Hospital; Seoul National University Hospital 和其他合作者主动,不招人
-
Ulsan University HospitalThe Korean Society of Hematology, AML/MDS Working Party未知
-
Asan Medical CenterKorea Research Institute of Bioscience & Biotechnology完全的
-
Asan Medical Center终止
-
Asan Medical CenterKorea Research Institute of Bioscience & Biotechnology未知
-
Asan Medical Center主动,不招人
-
Sabz BiomedicalsGene Therapy Research Center, Shariati Hospital, Tehran University of Medical Sciences, Iran; Research Institute for Oncology- Hematology and Cell Therapy (RIOHCT), Tehran University of Medical Sciences, Iran尚未招聘复发性 B 细胞急性淋巴细胞白血病 (ALL) | 难治性 B 细胞急性淋巴细胞白血病 (ALL)伊朗伊斯兰共和国
-
Seoul National University Hospital招聘中
-
Ulsan University HospitalThe Korean Society of Hematology CML working party未知
-
Cooperative Study Group A for Hematology未知
-
Samsung Medical CenterJin Yang Pharmaceutical暂停
-
Seoul National University Hospital招聘中
-
Asan Medical Center终止
-
Amgen终止复发/难治性急性髓系白血病 (AML)美国, 大韩民国, 澳大利亚, 日本, 德国, 加拿大
-
Korea Otsuka Pharmaceutical Co., Ltd.主动,不招人
-
Asan Medical Center完全的
-
Seoul St. Mary's HospitalJanssen, LP未知
-
Seoul National University Hospital完全的